Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis
Population Health Management · 2021-02 · 24 (1) · 122-132
DOI: 10.1089/pop.2019.0220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Population Health Management, online erschienen am 02.02.2021. Verfasst von Shirley Musich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research for Aging Populations, Optum, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Osteoarthritis, Tramadol. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Tramadol is a low-level opioid increasingly recommended to treat moderate-to-severe acute and chronic pain. Although characterized as having fewer opioid-related adverse events, the longer term safety of tramadol use among older adults has not been thoroughly documented. Thus, the primary objective was to examine the risk of safety events associated with chronic tramadol use compared to other chronic opioid use or no opioids among older adults with osteoarthritis. Safety events considered included: ≥3 emergency room (ER) visits, falls/hip fractures, cardiovascular (CVD) hospitalization, composite safety event hospitalization, and all-cause mortality. The study population included older adults ages ≥65 years diagnosed with osteoarthritis and classified into new or continuing tramadol use, new or continuing other opioid use, or nonuse. Inclusion criteria included: 6-month pre period and up to 33 months post period. Tramadol, other opioid, and no opioid users were 1:1 propensity-matched providing study populations of 25,899 within each category; 72% were new chronic opioid users. Multiple logistic regression or Cox proportional hazard ratios were used to document risk. Generally, tramadol users had fewer adverse event risks compared to other opioid users but higher risks than nonusers. New users of tramadol or other opioids had higher risks than continuing users. Tramadol use was associated with increased risk of multiple ER utilizations, falls/fractures, CVD hospitalizations, safety event hospitalizations, and mortality (new users only) compared to nonuse. Thus, although tramadol use may be appropriately recommended within a pain management strategy for older adults with osteoarthritis, careful monitoring for adverse safety events is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research for Aging Populations, Optum, Ann Arbor, Michigan, USA.
- Optum Enterprise Analytics, Eden Prairie, Minnesota, USA.
- UnitedHealthcare Medicare & Retirement, Minneapolis, Minnesota, USA.
- AARP Services, Inc., Washington, District of Columbia, USA.
Zitieren
APA
Musich, S., Wang, S. S., Schaeffer, J. A., Slindee, L., Kraemer, S., & Yeh, C. S. (2021). Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis. Population Health Management, 24(1), 122-132. https://doi.org/10.1089/pop.2019.0220
Vancouver
Musich S, Wang SS, Schaeffer JA, Slindee L, Kraemer S, Yeh CS. Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis. Population Health Management. 2021;24(1):122-132. doi:10.1089/pop.2019.0220
BibTeX
@article{Musich2021,
author = {Musich, Shirley and Wang, Shaohung S and Schaeffer, James A and Slindee, Luke and Kraemer, Sandra and Yeh, Charlotte S},
title = {Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis},
journal = {Population Health Management},
year = {2021},
volume = {24},
number = {1},
pages = {122--132},
doi = {10.1089/pop.2019.0220}
}
EUVIMED